{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:47Z","timestamp":1786982687803,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s13730-021-00625-7","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:02:57Z","timestamp":1626958977000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevation of serum fibroblast growth factor 23 level in a pediatric patient with lupus nephritis"],"prefix":"10.1007","volume":"11","author":[{"given":"Shunsuke","family":"Shimazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuro","family":"Kazukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Yamammoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Naruke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"625_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrendo.2009.196","volume":"5","author":"MS Razzaque","year":"2009","unstructured":"Razzaque MS. The FGF23-klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol. 2009;5:611\u20139.","journal-title":"Nat Rev Endocrinol"},{"key":"625_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.tem.2018.08.006","volume":"29","author":"Y Takahashi","year":"2018","unstructured":"Takahashi Y, Fukumoto S. FGF23 beyond phosphotropic hormone. Trends Endocrinol Metab. 2018;29:755\u201367.","journal-title":"Trends Endocrinol Metab"},{"key":"625_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/MNH.0000000000000514","volume":"28","author":"JL Babitt","year":"2019","unstructured":"Babitt JL, Sitara D. Crosstalk between FGF23, iron, erythropoietin, and inflammation in kidney disease. Curr Opin Nephrol Hypertens. 2019;28:304\u201310.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"625_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MNH.0000000000000232","volume":"25","author":"C Francis","year":"2016","unstructured":"Francis C, David V. Inflammation regulates FGF23 production. Cur Opin Nephrol Hypertens. 2016;25:325\u201332.","journal-title":"Cur Opin Nephrol Hypertens"},{"key":"625_CR5","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"625_CR6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630\u201340.","journal-title":"Arthritis Rheum"},{"key":"625_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/acr.21664","volume":"64","author":"BH Hahn","year":"2012","unstructured":"Hahn BH, Mcmahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64:797\u2013808.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"625_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","volume":"62","author":"I Endo","year":"2015","unstructured":"Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, et al. Nationwide survey of fibroblast growth factor 23 (FGF23) related hypophosphatemic disease in Japan: prevalence, biochemical data and treatment. Endocr J. 2015;62:811\u20136.","journal-title":"Endocr J"},{"key":"625_CR9","first-page":"423","volume":"112","author":"A Kuhn","year":"2015","unstructured":"Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M. The diagnosis and treatment of systemic lupus erythematosus. Dtsch Arztebl Int. 2015;112:423\u201332.","journal-title":"Dtsch Arztebl Int"},{"key":"625_CR10","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/acr.22035","volume":"65","author":"JM Pego-Reigosa","year":"2013","unstructured":"Pego-Reigosa JM, Cobo-Ib\u00e1\u0148ez T, Calvo-Al\u00e9n J, Loza-Santamar\u00eda E, Rahman A, Mu\u0148oz-Fern\u00e1ndez S, et al. Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systemic review. Arthritis Care Res (Hoboken). 2013;65:1775\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"625_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/art.25052","volume":"62","author":"EM Ginzler","year":"2010","unstructured":"Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA, et al. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Arthritis Rheum. 2010;62:211\u201321.","journal-title":"Arthritis Rheum"},{"key":"625_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2169\/internalmedicine.55.5507","volume":"55","author":"H Sato","year":"2016","unstructured":"Sato H, Kazama JJ, Murasawa A, Otani H, Abe A, Itoh S, et al. Serum fibroblast growth factor 23 (FGF23) in patients with rheumatoid arthritis. Intern Med. 2016;55:121\u20136.","journal-title":"Intern Med"},{"key":"625_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cyto.2016.12.022","volume":"91","author":"AL Resende","year":"2017","unstructured":"Resende AL, Elias RM, Wolf M, Reis LM, Graciolli FG, Santos GD, et al. Serum levels of fibroblast growth factor 23 are elevated in patients with active lupus nephritis. Cytokine. 2017;91:124\u20137.","journal-title":"Cytokine"},{"key":"625_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1442-200X.1997.tb03594.x","volume":"39","author":"S Takei","year":"1997","unstructured":"Takei S, Maeno N, Shigemori M, Imanaka H, Mori H, Nerome Y, et al. Clinical features of Japanese children and adolescents with systemic lupus erythematosus: results of 1980\u20131994 survey. Acta Paediatr Jpn. 1997;39:250\u20136.","journal-title":"Acta Paediatr Jpn"},{"key":"625_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1191\/0961203303lu259oa","volume":"12","author":"M Zabaleta-Lanz","year":"2003","unstructured":"Zabaleta-Lanz M, Vargas-Arenas RE, T\u03acpanes F, Daboin I, Atahualpa Pinto J, Bianco NE. Silent nephritis in systemic lupus erythematousus. Lupus. 2003;12:26\u201330.","journal-title":"Lupus"},{"key":"625_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10067-016-3491-7","volume":"36","author":"H Wakiguchi","year":"2017","unstructured":"Wakiguchi H, Takei S, Kubota T, Miyazono A, Kawano Y. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels. Clin Rheumatol. 2017;36:433\u20137.","journal-title":"Clin Rheumatol"},{"key":"625_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/rheumatology\/keu343","volume":"54","author":"J Ishizaki","year":"2015","unstructured":"Ishizaki J, Saito K, Nawata M, Mizuno Y, Tokunaga M, Sawamukai N, et al. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2015;54:405\u201312.","journal-title":"Rheumatology (Oxford)"},{"key":"625_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","volume":"94","author":"K Durlacher-Betzer","year":"2018","unstructured":"Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T, et al. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 2018;94:315\u201325.","journal-title":"Kidney Int"},{"key":"625_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41387-018-0037-x","volume":"8","author":"P Glosse","year":"2018","unstructured":"Glosse P, Fajol A, Hirche F, Feger M, Voelkl J, Lang F, et al. A high-fat diet stimulates fibtoblast growth factor 23 formation in mice through TNF\u03b1 upregulation. Nutr Diabetes. 2018;8:36.","journal-title":"Nutr Diabetes"},{"key":"625_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S, et al. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int. 2016;90:985\u201396.","journal-title":"Kidney Int"},{"key":"625_CR21","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.3390\/ijms20174195","volume":"20","author":"B Czaya","year":"2019","unstructured":"Czaya B, Faul C. The role of fibroblast growth factor 23 in inflammation and anemia. Int J Mol Sci. 2019;20:4195.","journal-title":"Int J Mol Sci"},{"key":"625_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/ard.2005.041673","volume":"65","author":"S Giannouli","year":"2006","unstructured":"Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis. 2006;65:144\u20138.","journal-title":"Ann Rheum Dis"},{"key":"625_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0268-960X(93)90006-P","volume":"7","author":"DM Keeling","year":"1993","unstructured":"Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 1993;7:199\u2013207.","journal-title":"Blood Rev"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-021-00625-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T12:54:58Z","timestamp":1643806498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-021-00625-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1007\/s13730-021-00625-7","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any potential conflicts of interest associated with this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}